LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News EARNINGS FLASH M impact Sep 21, 2026, 08:17 PM UTC

AnaptysBio reports 2Q EPS of $5.11

TradingView News reports AnaptysBio 2Q EPS of $5.11 for ANAB.

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

ANAB

Related stories

SNDK int Buy @ Rosenblatt pt 2400 Rosenblatt Management's FY28—FY30 framework calls for mid-to-high-teens revenue growth, approximately 80% Non-GAAP gross margin, 75% Non-GAAP operating margin, and 50% adjusted free-cash-flow margin. Management attributes its confidence in this four-year outlook partly to New Business Model agreements with eight of the world's largest NAND customers, which we estimate may cover approximately 65% of FY28 production. These agreements could increa SNDK int Buy @ Rosenblatt pt 2400 Rosenblatt Management's FY28—FY30 framework calls for mid-to-high-teens revenue growth, approximately 80% Non-GAAP gross margin, 75% Non-GAAP oper L impact | EARNINGS | Sep 21, 2026, 09:27 PM UTC Earnings for Tuesday Sept 22 Before Market: AZO, HERE, MLKN, THO After Market: AYTU, KBH, WOR H impact | EARNINGS | Sep 21, 2026, 08:51 PM UTC AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties AnaptysBio said Q2 collaboration revenue increased as Jemperli royalties rose, per its press release. M impact | EQUITY | Sep 21, 2026, 08:26 PM UTC AnaptysBio reports Q2 FY26 results; Jemperli and Quimilza milestones flagged AnaptysBio reported Q2 FY26 results. It said Jemperli is showing year-over-year growth, with potential FDA actions and a litigation judgment expected within 6 months. The company a M impact | EQUITY | Sep 21, 2026, 08:21 PM UTC AnaptysBio Q2 net income more than doubles to $177.3 million on 23.5% revenue rise AnaptysBio posted Q2 net income from continuing operations of USD 177.3 million, versus USD 5.7 million a year earlier. Q2 collaboration revenue rose 23.47% year over year to USD 2 M impact | EARNINGS | Sep 21, 2026, 08:17 PM UTC AnaptysBio reports 2Q revenue of $27.5M TradingView News says AnaptysBio 2Q revenue was $27.5M. M impact | EARNINGS | Sep 21, 2026, 08:17 PM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.